Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
11/2011
11/02/2011CN102228606A Traditional Chinese medicine composition for treating hematuria of foals
11/02/2011CN102228602A Traditional Chinese medicine formula and method for treating kidney channel tissue disease
11/02/2011CN102228572A Traditional Chinese medicine composition for treating cattle hematuria
11/02/2011CN102228536A Chinese herbal extract for treating diabetic nephropathy and preparation method thereof
11/02/2011CN102228521A New Chinese medicine for treating early and middle-stage diabetic nephropathy
11/02/2011CN102228520A Medicine for treating kidney calculus and preparation method thereof
11/02/2011CN102228513A Medicinal composition for treating diabetes or diabetic complications and preparation method thereof
11/02/2011CN102228492A Notoginseng root tea and preparation method thereof
11/02/2011CN102228484A Chinese medicinal preparation Jinshuibao oral liquid and preparation method thereof
11/02/2011CN102228471A Use of cat isaria mycelium
11/02/2011CN102228457A Pharmaceutical composition for treating diabetes and complication thereof
11/02/2011CN102228451A Method for preparing tamsulosin hydrochloride sustained release preparation
11/02/2011CN102008697B Medicinal liquor for curing nephropathy and preparation method thereof
11/02/2011CN101940697B Medicament for treating prostatitis
11/02/2011CN101773620B Heat-clearing stranguria-treating drug
11/02/2011CN101612246B Medicine composition for treating nephritis, preparation method and quality control method
11/02/2011CN101066294B Chinese medicine prepn for invigorating kidney to reduce urination and its prepn
11/02/2011CN101014708B Use of antisense oligonucleotides or sirna to suppress expression of eif-5a1
11/01/2011US8048890 Analgesics; neuropathic pain; headaches; muscle relaxants; incontence; tinnitus; diarrhea; antiarrhythmia agents; antiischemic agents; antiinflammatory agents; antiulcer agents; antidepressants; antiepileptic agents
11/01/2011CA2490277C Use of vasopeptidase inhibitors in the treatment of nephropathy
11/01/2011CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011CA2468826C Benzazole derivatives for the treatment of scleroderma
11/01/2011CA2466418C Lipoxin a4 analogs
11/01/2011CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds
11/01/2011CA2439269C Pharmaceutical salts of 1-phenyl-3-dimethylaminopropane compounds
11/01/2011CA2402247C Biodegradable immunomodulatory formulations and methods for use thereof
10/2011
10/27/2011WO2011132201A1 A pharmaceutical composition comprising antiplatelet agents and an erythropoiesis stimulating agent
10/27/2011WO2011131026A1 Furo[3, 2-g]chromene compounds and uses thereof
10/27/2011WO2011130824A1 Hb-egf composition and use thereof to treat a condition associated with enhanced urothelium permeability
10/27/2011WO2011087769A3 Nutritional compositions and methods for optimizing dietary acid-base potential
10/27/2011US20110263721 Aryl di-substituted propenone compounds
10/27/2011US20110263718 Process for the preparation of o-desmethylvenlafaxine
10/27/2011US20110263711 1-(2-fluorobiphenyl-4-yl)-alkyl carboxylic acid derivatives for the therapy of transthyretin amyloidosis
10/27/2011US20110263704 Methods of Using Cycloalkylmethylamines
10/27/2011US20110263699 1-Phenyl-2-DimethylaminomethylCyclohexane Compounds and Therapies for Depressive Symptoms, Pain and Incontinence
10/27/2011US20110263684 Lipid Formulated Compositions and Methods for Inhibiting Expression of Serum Amyloid A Gene
10/27/2011US20110263658 Renin inhibitors
10/27/2011US20110263656 Pirfenidone Treatment for Patients with Atypical Liver Function
10/27/2011US20110263651 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263640 8-azabicyclo[3.2.1]oct-2-ene derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
10/27/2011US20110263621 NEW COMBINATION OF ACTIVE INGREDIENTS CONTAINING AN a1-ANTAGONIST AND A PDE 4 INHIBITOR
10/27/2011US20110263612 Compounds that modulate intracellular calcium
10/27/2011US20110263607 Alpha helix mimetics in the treatment of cancer
10/27/2011US20110263557 Compounds and compositions as modulators of gpr119 activity
10/27/2011US20110263555 TGR5 Modulators and Methods of Use Thereof
10/27/2011US20110263544 1-Phenylpyrrole Derivatives
10/27/2011US20110263504 Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
10/27/2011US20110263501 Growth Hormone Conjugate with Increased Stability
10/27/2011US20110263494 Nonsteroidal compounds useful as modulators of glucocorticoid receptor ap-1 and/or nf-kappab acitivity and use thereof
10/27/2011US20110263482 Complement inhibitors
10/27/2011US20110263480 Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
10/27/2011US20110262566 Novel useful therapeutic agent for lower urinary tract symptom
10/27/2011US20110262511 Novel Uses
10/27/2011US20110262429 Human timp-1 antibodies
10/27/2011US20110259350 Methods of Using SDF-1 (CXCL12) as a Diagnostic and Mesenchymal Stem Cell (Multipotent Stromal Cell)-Specific Therapeutic Biomarker for the Treatment of Kidney Injury and Other Major Organs
10/26/2011EP2380881A1 Novel bicyclic heterocyclic compound
10/26/2011EP2380850A1 Modified sodium-montmorillonite, preparing method and uses thereof
10/26/2011EP2380578A1 Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent
10/26/2011EP2380570A1 Pharmaceutical composition for preventing and treating diabetic nephropathy and preparation method thereof
10/26/2011EP2379533A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
10/26/2011EP2379518A1 Thiadiazole-substituted arylamides
10/26/2011EP2379094A1 Polysaccharide from the goji berry fruit for kidneys and pancreas
10/26/2011EP1864994B1 Par-2 agonist
10/26/2011EP1259481B1 Substituted benzoylguanidines, method for their production, their use as a medicament or diagnostic agent and a medicament containing the same
10/26/2011CN102225896A Ether derivatives of rhein and their therapeutic use
10/26/2011CN102225201A New application of glycolytic inhibitor
10/26/2011CN102225181A Medicament for treating benign prostatic hyperplasia disease and preparation method thereof
10/26/2011CN102225167A Traditional Chinese medicine composition for treating pediatric acute nephritis and preparation method thereof
10/26/2011CN102225159A Traditional Chinese medicine compound for treating diseases such as nephritis, renal failure and uremia and preparation thereof
10/26/2011CN102225110A Propolis wine with heydyotis and its preparation method
10/26/2011CN102225088A Application of Eucommia lignans in preparing medicaments for preventing and treating hypertension-induced renal injury
10/26/2011CN102225081A Thorny elaeagnus extract as well as preparation method and application thereof
10/26/2011CN101711851B Traditional Chinese medicine composition for treating symptoms of renal calculus and preparation method thereof
10/26/2011CN101676266B Deuterium-substituted omega-diphenylurea and its derivatives, as well as pharmaceutical composition containing the same
10/26/2011CN101647946B Hyperplasia-ablating pill for treating prostate hyperplasia
10/26/2011CN101618172B Traditional Chinese medicine for treating hepatitis B, cirrhosis, liver cancer and liver ascites
10/26/2011CN101584764B Medicinal dripping pill for treating chronic cystitis
10/26/2011CN101301324B Oral Chinese medicine for treating bloody urine caused by prostatic swelling
10/25/2011US8044182 Adiponectin and uses thereof
10/25/2011US8044070 Heteroaryloxy nitrogenous saturated heterocyclic derivative
10/25/2011US8044042 Thienotriazolodiazepine compound and medicinal use thereof
10/25/2011US8044040 e.g. 3-{3-Cyano-6-[(2,2-dimethyl-propyl)-methyl-amino]-5-fluoro-pyridin-2-ylamino}-N-methoxy-4-methyl-benzamide; via p38 kinase inhibition; (anilino)(halo)pyrimidine or (anilino)(amino)pyrimidine derivatives; rheumatoid arthritis, psoriasis, Crohn's Disease, osteoarthritis or osteoporosis
10/25/2011US8044018 Reagents and methods for smooth muscle therapies
10/25/2011US8043855 vector contains an adenoviral genome from which the open reading frames E1 and/or E3 have been deleted, but retains enough sequence to make it able to replicate in vitro; also contains a DNA sequence regulated by promoters that encode for fibrosis treatment proteins
10/25/2011CA2415923C Novel tumor antigen useful in diagnosis and therapy of bladder, ovary, lung and kidney cancers
10/20/2011WO2011129399A1 Srebp inhibitor
10/20/2011WO2011128370A1 Synthesis of duloxetine and/or pharmaceutically acceptable salts thereof
10/20/2011WO2011127625A1 Method for regulating microrna content in organisms and uses thereof
10/20/2011WO2011075636A3 Wise binding agents and epitopes
10/20/2011WO2011049327A3 A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
10/20/2011WO2011047173A9 Pharmaceutical compositions for oral administration
10/20/2011US20110257726 Scaffolds for organ reconstruction and augmentation
10/20/2011US20110257271 Derivatives of dimethylcurcumin
10/20/2011US20110257252 Novel antithrombotic diadenosine tetraphosphates and related analogs
10/20/2011US20110257243 3-phenoxymethylpyrrolidine compounds
10/20/2011US20110257233 Benzoisothiazolones as inhibitors of phosphomannose isomerase
10/20/2011US20110257208 Compounds useful as faah modulators and uses thereof
10/20/2011US20110257202 Therapeutic Compositions and Methods for Treating Chronic Kidney Disease Associated with a Metabolic Imbalance
10/20/2011US20110257194 Substituted oxindol derivatives and medicaments containing the same
10/20/2011US20110257177 Benzylthiotetrazole inhibitors of store operated calcium release
1 ... 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 ... 562